Literature DB >> 16041669

Immunoaffinity separation of plasma proteins by IgY microbeads: meeting the needs of proteomic sample preparation and analysis.

Lei Huang1, Gulia Harvie, Jerald S Feitelson, Kosi Gramatikoff, David A Herold, David L Allen, Ravi Amunngama, Rachel A Hagler, Michael R Pisano, Wei-Wei Zhang, Xiangming Fang.   

Abstract

Separation of complex protein mixtures that have a wide dynamic range of concentration, such as plasma or serum, is a challenge for proteomic analysis. Sample preparation to remove high-abundant proteins is essential for proteomics analysis. Immunoglobulin yolk (IgY) antibodies have unique and advantageous features that enable specific protein removal to aid in the detection of low-abundant proteins and biomarker discovery. This report describes the efficiency and effectiveness of IgY microbeads in separating 12 abundant proteins from plasma with an immunoaffinity spin column or LC column. The protein separation and sample preparation process was monitored via SDS-PAGE, 2-DE, LC-MS/MS, or clinical protein assays. The data demonstrate the high specificity of the protein separation, with removal of 95-99.5% of the abundant proteins. IgY microbeads against human proteins can also selectively remove orthologous proteins of other mammals such as mouse, rat, etc. Besides the specificity and reproducibility of the IgY microbeads, the report discusses the factors that may cause potential variations in protein separation such as protein-protein interactions (known as "Interactome"), binding and washing conditions of immunoaffinity reagents, etc. A novel concept of Seppromics is introduced to address methodologies and science of protein separation in a context of proteomics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041669     DOI: 10.1002/pmic.200401277

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  40 in total

Review 1.  Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.

Authors:  Wei-Jun Qian; Jon M Jacobs; Tao Liu; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-08-03       Impact factor: 5.911

2.  Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry.

Authors:  Tao Liu; Wei-Jun Qian; Heather M Mottaz; Marina A Gritsenko; Angela D Norbeck; Ronald J Moore; Samuel O Purvine; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-07-19       Impact factor: 5.911

3.  Clinical proteomics: present and future prospects.

Authors:  Nicole M Verrills
Journal:  Clin Biochem Rev       Date:  2006-05

4.  Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseases.

Authors:  Xin Wei; Lingjun Li
Journal:  Int J Clin Exp Pathol       Date:  2008-06-20

5.  Variation in protein levels obtained from human blood cells and biofluids for platelet, peripheral blood mononuclear cell, plasma, urine and saliva proteomics.

Authors:  L Katie Crosley; Susan J Duthie; Abigael C Polley; Freek G Bouwman; Carolin Heim; Francis Mulholland; Graham Horgan; Ian T Johnson; Edwin C Mariman; Ruan M Elliott; Hannelore Daniel; Baukje de Roos
Journal:  Genes Nutr       Date:  2009-04-29       Impact factor: 5.523

6.  Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy.

Authors:  Wei-Jun Qian; David T Kaleta; Brianne O Petritis; Hongliang Jiang; Tao Liu; Xu Zhang; Heather M Mottaz; Susan M Varnum; David G Camp; Lei Huang; Xiangming Fang; Wei-Wei Zhang; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2008-07-15       Impact factor: 5.911

Review 7.  Status and prospects for discovery and verification of new biomarkers of cardiovascular disease by proteomics.

Authors:  Robert E Gerszten; Aarti Asnani; Steven A Carr
Journal:  Circ Res       Date:  2011-08-05       Impact factor: 17.367

8.  Assessment of albumin removal from an immunoaffinity spin column: critical implications for proteomic examination of the albuminome and albumin-depleted samples.

Authors:  Rebekah L Gundry; Melanie Y White; Julie Nogee; Irina Tchernyshyov; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2009-04       Impact factor: 3.984

9.  The effects of abundant plasma protein depletion on global glycan profiling using nanoLC FT-ICR mass spectrometry.

Authors:  Michael S Bereman; David C Muddiman
Journal:  Anal Bioanal Chem       Date:  2010-01-20       Impact factor: 4.142

10.  The development of an integrated platform to identify breast cancer glycoproteome changes in human serum.

Authors:  Zhi Zeng; Marina Hincapie; Brian B Haab; Samir Hanash; Sharon J Pitteri; Steven Kluck; Jason M Hogan; Jacob Kennedy; William S Hancock
Journal:  J Chromatogr A       Date:  2009-09-16       Impact factor: 4.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.